Send the following on WhatsApp
Continue to ChatFDA to Review Topical PDE4-Inhibitor Roflumilast for Psoriasis https://www.businessline.global/fda-to-review-topical-pde4-inhibitor-roflumilast-for-psoriasis/biotech-and-pharma/
FDA to Review Topical PDE4-Inhibitor Roflumilast for Psoriasis https://www.businessline.global/fda-to-review-topical-pde4-inhibitor-roflumilast-for-psoriasis/biotech-and-pharma/